Improving tumor detection and treatment using a special fluorescent probe
Optimization of aminolevulinic acid-protoporphyrin IX for fluorescence-guided tumor resection and treatment
['FUNDING_R15'] · SAINT JOSEPH'S UNIVERSITY · NIH-10818914
This study is looking at ways to make tumors easier to see during surgery by using a special substance called aminolevulinic acid, which helps doctors remove cancer more effectively, so patients can have better outcomes.
Quick facts
| Phase | ['FUNDING_R15'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | SAINT JOSEPH'S UNIVERSITY (nih funded) |
| Locations | 1 site (PHILADELPHIA, UNITED STATES) |
| Trial ID | NIH-10818914 on ClinicalTrials.gov |
What this research studies
This research focuses on enhancing the effectiveness of aminolevulinic acid (ALA) and its metabolite protoporphyrin IX (PpIX) for better imaging and treatment of tumors during surgery. By investigating the factors that limit the fluorescence of PpIX in tumors, the research aims to improve the visibility of tumors, allowing for more precise removal and treatment. The study will explore the use of existing medications to increase the fluorescence of PpIX, potentially leading to better outcomes for patients undergoing tumor resection. Patients may benefit from improved surgical techniques that allow for more complete removal of cancerous tissues.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients undergoing surgery for malignant tumors who could benefit from enhanced imaging techniques.
Not a fit: Patients with non-malignant tumors or those not requiring surgical intervention may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective tumor surgeries and improved cancer treatment outcomes.
How similar studies have performed: Previous research has shown promise in using fluorescence-guided techniques for tumor resection, indicating potential for success in this approach.
Where this research is happening
PHILADELPHIA, UNITED STATES
- SAINT JOSEPH'S UNIVERSITY — PHILADELPHIA, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: CHEN, BIN — SAINT JOSEPH'S UNIVERSITY
- Study coordinator: CHEN, BIN
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Cancers, neoplasm/cancer